These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38577444)

  • 1. Clinical features and prognostic factors of duodenal neuroendocrine tumours: A comparative study of ampullary and nonampullary regions.
    Fang S; Shi YP; Wang L; Han S; Shi YQ
    World J Gastrointest Oncol; 2024 Mar; 16(3):907-918. PubMed ID: 38577444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of therapeutic outcomes in patients with nonampullary duodenal neuroendocrine tumors (NADNETs): A multicenter retrospective study.
    Lee SW; Sung JK; Cho YS; Bang KB; Kang SH; Kim KB; Kim SH; Moon HS; Song KH; Kim SM; Chung IK; Lee DS; Jeong HY; Youn SJ
    Medicine (Baltimore); 2019 Jun; 98(26):e16154. PubMed ID: 31261543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.
    Weatherall T; Denbo J; Sharpe J; Martin M; O'Brien T; Gupta R; Groshart K; Behrman S; Dickson P
    World J Surg; 2017 Mar; 41(3):844-850. PubMed ID: 27743074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine tumours of the duodenum. Clinical aspects, pathomorphology and therapy.
    Witzigmann H; Loracher C; Geissler F; Wagner T; Tannapfel A; Uhlmann D; Caca K; Hauss J; Hehl JA
    Langenbecks Arch Surg; 2002 Jan; 386(7):525-33. PubMed ID: 11819111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy.
    Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Spolverato G; Maithel SK; Pawlik TM
    J Surg Oncol; 2020 Sep; 122(3):442-449. PubMed ID: 32470159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection.
    Tran CG; Sherman SK; Suraju MO; Nayyar A; Gerke H; Abiad RGE; Chandrasekharan C; Ear PH; O'Dorisio TM; Dillon JS; Bellizzi AM; Howe JR
    Ann Surg Oncol; 2022 Jan; 29(1):75-84. PubMed ID: 34515889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature.
    Dasari BVM; Al-Shakhshir S; Pawlik TM; Shah T; Marudanayagam R; Sutcliffe RP; Mirza DF; Muiesan P; Roberts KJ; Isaac J
    J Gastrointest Surg; 2018 Sep; 22(9):1652-1658. PubMed ID: 29869091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined.
    Zhang XF; Wu XN; Tsilimigras DI; Poultsides G; Rocha F; Abbott DE; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM;
    J Surg Oncol; 2019 Dec; 120(8):1302-1310. PubMed ID: 31680243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional endoscopic mucosal resection versus modified endoscopic mucosal resection for duodenal neuroendocrine tumor.
    Noh JH; Kim DH; Park K; Na HK; Ahn JY; Lee JH; Jung KW; Choi KD; Song HJ; Lee GH; Jung HY
    Surg Endosc; 2023 May; 37(5):3884-3892. PubMed ID: 36717428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for lymph node metastasis and indication of local resection in duodenal neuroendocrine tumors.
    Nakao E; Namikawa K; Hirasawa T; Nakano K; Tokai Y; Yoshimizu S; Horiuchi Y; Ishiyama A; Yoshio T; Nunobe S; Fujisaki J
    JGH Open; 2022 Mar; 6(3):189-195. PubMed ID: 35355673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of endoscopic resection using bipolar snare for nonampullary duodenal tumours in familial adenomatous polyposis patients.
    Inoki K; Nakajima T; Nonaka S; Abe S; Suzuki H; Yoshinaga S; Oda I; Yamada M; Takatsu M; Yoshida H; Taniguchi H; Sekine S; Ohe Y; Saito Y
    Fam Cancer; 2018 Oct; 17(4):517-524. PubMed ID: 29189961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A "Watch and Wait" Strategy Involving Regular Endoscopic Surveillance Is Safe for Many Patients with Small, Sporadic, Grade 1, Non-Ampullary, Non-Functioning Duodenal Neuroendocrine Tumours.
    Exarchou K; Moore AR; Smart HL; Duckworth CA; Howes N; Pritchard DM
    Neuroendocrinology; 2021; 111(8):764-774. PubMed ID: 32937631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ampullary neuroendocrine neoplasms: surgical experience of a rare and challenging entity.
    Milanetto AC; Pasquali C; Da Broi M; Brambilla T; Capretti G; Zerbi A
    Langenbecks Arch Surg; 2018 Aug; 403(5):581-589. PubMed ID: 30043166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable long-term outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumor.
    Matsueda K; Kanesaka T; Kitamura M; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Honma K; Miyashiro I; Ishihara R
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3329-3336. PubMed ID: 34142385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumors Have Similar Disease-Specific Survival Outcome.
    Mirzaie S; Park JY; Mederos MA; Girgis MD
    J Gastrointest Surg; 2023 Nov; 27(11):2365-2372. PubMed ID: 37552388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic mucosal resection using a ligation device for duodenal neuroendocrine tumors: a simple method.
    Inokuchi Y; Hayashi K; Kaneta Y; Okubo Y; Watanabe M; Furuta M; Machida N; Maeda S
    Ther Adv Gastrointest Endosc; 2022; 15():26317745221103735. PubMed ID: 35706683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases.
    Adsay V; Ohike N; Tajiri T; Kim GE; Krasinskas A; Balci S; Bagci P; Basturk O; Bandyopadhyay S; Jang KT; Kooby DA; Maithel SK; Sarmiento J; Staley CA; Gonzalez RS; Kong SY; Goodman M
    Am J Surg Pathol; 2012 Nov; 36(11):1592-608. PubMed ID: 23026934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of margin status on outcomes after endoscopic resection of well-differentiated duodenal neuroendocrine tumors.
    Ragheb J; Mony S; Klapman J; Erim T; Reagan A; Butler R; Dong Y; Cruise M; Centeno BA; Bejarano P; Stevens T; Hayat U; Bhatt A
    Gastrointest Endosc; 2021 Sep; 94(3):580-588. PubMed ID: 33676923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable long-term survival outcomes of endoscopic therapy versus surgical therapy for T1-2N0M0 duodenal neuroendocrine tumors.
    Liu Z; Gao J; Wang P; Yin F; Zeng C; Chen Y
    Surg Endosc; 2023 Jul; 37(7):5444-5452. PubMed ID: 37036503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.